RHEUMON

This brand name is authorized in Austria, New Zealand, Poland, Turkey

Active ingredients

The drug RHEUMON contains one active pharmaceutical ingredient (API):

1 Etofenamate UNII KZF0XM66JC - ETOFENAMATE

Etofenamate is a flufenamic acid derivative, which is readily transported through the skin and concentrated in inflamed tissue, where it exerts anti-inflammatory and analgesic effects by inhibiting the release of histamine, lysosomal enzymes and prostaglandin. Read about Etofenamate

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
M02AA06	Etofenamate	M Musculo-skeletal system → M02 Topical products for joint and muscular pain → M02A Topical products for joint and muscular pain → M02AA Antiinflammatory preparations, non-steroids for topical use
Discover more medicines within M02AA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7498
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100077643
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8698856340146, 8698856510150, 8698856750167, 8698856750174